Expired European patentEurope
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
EP 0752248 B1 · Applicant: IDEC PHARMACEUTICALS CORPORATION
Overview
The published document from the EPO: abstract, claims, description and drawings. Open it full size
Read the whole patent
Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 12, 1993 and granted September 27, 2000. A European patent lasts at most 20 years from filing, so its term ended November 12, 2013.
- A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by May 12, 2019.
- We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledNovember 12, 1993
PublishedJanuary 8, 1997
GrantedSeptember 27, 2000
Term endedNovember 12, 2013
Application numberEP 96200772
Classification (CPC)A61K47/6849 +2 more
Timeline
Timeline From EPO dates
Sources & verification
Official EPO records
Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.